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Abstract 
 Recent studies indicate that microglia originate from immature progenitors in the yolk 
sac. After birth, microglial populations are maintained under normal conditions via 
self-renewal without the need to recruit monocyte-derived microglial precursors. 
Peripheral cell invasion of the brain parenchyma can only occur with disruption of the 
blood-brain barrier. Here, we report an autopsy case in which cells derived from 
umbilical cord blood differentiated into ramified microglia in the host brain parenchyma. 
Although the blood-brain barrier and glia limitans prevented invasion of these 
donor-derived cells, most of the invading donor-derived ramified cells were maintained 
in the cortical zone. This result suggests invasion of donor-derived cells occurs through 
the pial membrane. 
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Introduction 
Microglia, the only immunocompetent cells in the central nervous system (CNS), 
originate from progenitors derived from the yolk sac (1, 2). Studies have shown that 
after birth, microglia maintain their numbers under normal conditions by self-renewal 
without the recruitment of monocyte-derived microglia precursors (2, 3). Although 
there is currently no specific marker to fully distinguish resident microglia from 
monocyte-derived macrophages, some studies have shown that microglia and peripheral 
blood cell-derived macrophages can be distinguished by the presence of surface markers 
such as CCR2 and CX3CR1, even under inflammatory conditions (4, 5). Moreover, a 
human study showed that Y chromosome-bearing male cells cannot differentiate into 
microglia in the CNS of a female host after bone marrow transplantation (6). However, 
bone marrow stem cells and peripheral monocytes can differentiate into microglia-like 
cells in vitro (7, 8), suggesting that one of the most important barriers preventing the 
recruitment of microglial precursors from the peripheral blood is the blood-brain barrier 
(BBB). Indeed, irradiation or the alkylating agent busulfan can be used to disrupt the 
BBB, enabling the invasion and maintenance of bone marrow-derived cells in the brain 
parenchyma (9). 
In a mouse study, stress induced the recruitment of bone marrow-derived monocytes to 
the brain parenchyma (10). However, the results of many other studies do not clarify the 
origin of microglia in human adult brain. Here, we report an autopsy case where 
umbilical cord blood-derived cells differentiated into ramified microglia in the host 
brain parenchyma. 
 Material and Methods 
Case report 
A 51-year-old Japanese woman noticed swelling of her nasal floor at the age of 48; she 
was diagnosed with NK/T-cell lymphoma at our hospital. She received focal radiation 
therapy targeting the paranasal, maxillary, and ethmoid sinuses, the parotid glands, and 
orbits from the right and left side (40 Gy) following three courses of DeVIC 
(dexamethasone, etoposide, ifosfamide, and carboplatin) chemotherapy. Additionally, 
she received Novalis Shaped Beam Surgery (12 Gy). After treatment, she achieved 
complete remission (CR); two months after chemotherapy, she received a cord blood 
stem cell transplant (CBSCT) from a male donor with whom there are two HLA 
mismatches (Donor; A*31:01, A*33:03, B*51:01, B*40:03, DRB1*08:02, DRB1*14:05, 
Host; A*31:01, A*02:01, B*51:01, B*40:02, DRB1*08:02, DRB1*14:05). Acute 
graft-versus-host disease (GVHD) was mild and well controlled by oral administration 
of tacrolimus. Four months after CBSCT, the patient suffered shingles of the right 12th 
thoracic segment and was treated with acyclovir; however, herpes zoster developed into 
cervical myelitis. Combined therapy with steroid pulse treatment and intravenous 
administration of gamma globulin was effective. Two years after CBSCT, she 
experienced muscle weakness and sensory disturbance of the lower extremities. Her 
symptoms gradually worsened although steroid pulse treatment provided slight 
improvement. Positron emission tomography (PET) showed relapse to the liver. Her 
general condition worsened and her consciousness deteriorated. Additionally she was 
given a single intrathecal admission of methotrexate (15 mg) two weeks before her 
death. She died 29 months after CBSCT.      
A general autopsy was performed 3 hours after death. The final diagnosis of the central 
nervous system was relapse to the spinal cord and inflammation of the left medulla with 
normal finding of the cerebrum and cerebellum except for a small area showing rude 
construction of the cortex in the left mid-frontal gyrus.   
Immunohistochemistry 
The brain was fixed with 10% buffered formalin. Multiple tissue blocks were embedded 
in paraffin, and 6-µm sections were cut and immunostained using a Liquid DAB+ 
Substrate Chromogen System kit (DAKO, Tokyo, Japan) and a TMB Peroxidase 
Substrate kit (Vector, Burlingame, CA). The sections were counterstained with 
hematoxylin. Primary antibodies included rabbit polyclonal anti-Iba-1 (Wako; Osaka, 
Japan; 1:8000), anti-GFAP (Sigma; Tokyo, Japan; 1:10000), and anti-CX3CR1 (Abcam; 
Tokyo, Japan; 1:100), rabbit monoclonal anti-CCR2 (Abcam; 1:4000), and mouse 
monoclonal anti-HLA-A2 (MBL; Nagoya, Japan; 1:100). Appropriate antigen retrieval 
methods were applied to each primary antibody. 
In site hybridization 
We used a commercial kit to identify the Y chromosome. Briefly, 5-µm sections from 
formalin-fixation paraffin-embedded blocks were deparaffinized, re-hydrated, and 
predigested with one drop of pepsin solution. The sections were incubated with 
hybridization solution containing ZytoDot CEN Yq12 Probe (ZytoVision; Bremerhaven, 
Germany) overnight at 37℃. The ZytoDot CISH Implementation Kit (ZytoVision) was 
used to visualize the hybridization products. After staining, the products were 
double-stained with anti-Iba-1 antibodies. 
 
Results 
To study the migration of donor-derived cells into the central nervous system (CNS) of 
the host, we performed immunohistochemistry with anti-HLA-A2 antibodies that could 
distinguish donor-derived cells from host cells. Interestingly, donor-derived HLA-A2(+) 
cells were found in the cortex and around vessels (Fig. 1A-C). HLA-A2(+) cells often 
seemed to have accumulated in the cortical region (Fig. 1A). Very few were observed in 
the deep white matter. Invading HLA-A2(+) cells in the cortical region were 
morphologically ramified, similar to microglia (Fig. 1B). However, 
immunohistochemical staining of the C5 lesion with anti-HLA-A2 antibodies showed a 
higher number of HLA-A2(+) cells in the parenchyma (Fig. 1D, E). Moreover, 
HLA-A2(+) cells are morphologically round in shape or ring-shaped, but not ramified 
(Fig. 1D, E). 
Next, we performed double staining to investigate graft cells differentiation into 
microglia or astrocytes. HLA-A2(+) cells stained positive for Iba-1, representative of 
microglia (Fig. 2A), but not GFAP specific to astrocytes (Fig. 2B). Since these results 
suggest the graft cells differentiated into microglia, we also performed in situ 
hybridization with anti-Yq12 probes. Although almost all cells in the sample from a 
male positive control showed a brown dot in their nuclei, and cells in the sample from a 
female negative control had no brown dot in their nuclei, only a few cells in the sample 
from the patient had a brown dot in the nuclei, indicating Y chromosome-positive cells 
from the male donor (Fig. 2C-E). Moreover, in situ hybridization with anti-Yq12 probes 
following immunohistochemistry with anti-Iba-1 antibodies showed that Y 
chromosome-positive cells from the male donor were Iba-1-positive (Fig. 2F). CCR2 
and CX3CR1 are very important to distinguish resident microglia and 
monocyte-originating microglia-like cells; thus, we next explored the expression of 
CCR2 and CX3CR1 on the HLA-A2(+) cells. About 60% of the HLA-A2(+) cells were 




Our case showed that umbilical cord blood stem cell-derived precursors could 
differentiate into CX3CR1(+)CCR2(-)Iba-1(+) ramified microglia even without 
irradiating the brain, whereas previous clinical studies did not show donor-derived cells 
entering the CNS parenchyma and transformation to microglia (6).  
Clinical conditions differed between our case and previous cases. First, our patient had 
an event of herpes zoster myelitis and relapse to the spinal cord, perhaps including 
meningitis of the whole brain. Moreover, an area of rude construction of the cortex in 
the left mid-frontal gyrus may indicate a trace of herpes zoster virus-induced 
encephalitis. Indeed, donor-derived cells can enter the recipient brain and differentiate 
into microglia after severe streptococcal meningitis (11). Bacterial meningitis often 
destroys the BBB and pial membrane, allows donor-derived cells to easily enter the 
CNS parenchyma. Even after meningitis, we often observe abnormal meningeal 
findings. Massengale et al. showed that no donor-derived cells enter the CNS 
parenchyma even with brain injury (12). Ajami et al. also reported that infiltrating 
monocytes in an inflammatory site have a short life and do not contribute to the resident 
microglia pool (13). Although it is considered the effect of meningitis carcinomatosa 
due to relapse to the spinal cord, our case showed no trace of meningitis.  
Second, the effect of chemotherapy and focal radiation therapy should be considered. 
The fact that donor-derived cells had not invade the deep white matter of the recipient is 
consistent with the possibility that there was no brain irradiation, as has been shown in 
head-shielded mouse models (14). Indeed, we rarely observed donor-derived microglia 
in the deep white matter, thalamus, and basal ganglia, although we found donor-derived 
perivascular cells; however, inflammation of the left medulla as observed in the final 
diagnosis may be due to the direct effect of focal irradiation. Since the alkylating agent 
busulfan can cause bone marrow-derived cells to penetrate the brain parenchyma (9), 
DeVIC chemotherapy may also disrupt the BBB. However, donor-derived ramified cells 
were rare in the deep region of the brain suggesting the BBB in our patient was 
sufficiently intact to prevent invasion of donor-derived cells. Although Unger et al. did 
not provide information pertaining to irradiation and chemotherapy (6), all patients 
likely received aggressive chemotherapy as pretreatment before bone marrow 
transplantation for leukemia or lymphoma. Nevertheless, no donor-derived cells 
differentiated into ramified microglia. The fact that donor-derived cells did not invade 
the deep white matter of the recipient is considered to be consistent with the possibility 
that chemotherapy had a minimal effect, as noted previously. Moreover, even if a single 
intrathecal admission of methotrexate could disrupt the BBB, it appears highly 
improbable that invading cells differentiated into CX3CR1(+)CCR2(-)Iba-1(+) ramified 
microglia indicating the resting form within two weeks. 
 In conclusion, we report an autopsy case in which cells derived from umbilical cord 
blood differentiated into ramified microglia in the host brain parenchyma. Although the 
BBB and glia limitans prevented invasion of these donor-derived cells, most of the 
invading donor-derived ramified cells remained in the cortical zone. This result suggests 
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Immunohistochemistry of HLA-A2 with hematoxylin staining. (A) HLA-A2(+) cells 
accumulated in the cortex (brown cells in the circle). (B) HLA-A2(+) cells with a 
ramified form (arrow). (C) A HLA-A2(+) cell showing a round shape around a vessel 
(arrow). HLA-A2(+) cells with a round form or ring form in the C5 lesion of the spinal 
cord at lower magnification (D) or at a higher magnification (E).  
 
Figure 2 
Double staining of donor-derived cells by immunohistochemistry (A, B, D, E) and in 
situ hybridization (C, D, E, F). (A) Double staining of donor-derived cells with 
anti-HLA-A2 antibodies (brown) and anti-Iba1 antibodies (blue). The inset shows the 
image at higher magnification. (B) Double staining of donor-derived cells with 
anti-HLA-A2 antibodies (brown) and anti-GFAP antibodies (blue). The inset shows the 
image at a higher magnification. (C) In situ hybridization of the sample from the patient 
by using anti-Yq12 probes (brown dot) with the staining of nuclei by Mayer’s 
hematoxylin solution. Arrows show Yq12(+) cells, indicating donor origin. The inset 
shows the image at higher magnification. (D) In situ hybridization of the sample from 
the positive control. The inset shows the image at a higher magnification. Arrows show 
Yq12(+) cells. (E) In situ hybridization of the sample from the negative control. (F) 
Double staining of donor-derived cells by using anti-Yq12 probes (brown dot) and 
anti-Iba antibodies (blue). Arrows show double-positive cells, indicating donor origin, 
and arrowheads show Iba-1(+)Yq12(-) cells, indicating host origin. The inset shows the 
image at higher magnification.  
 
Figure 3 
Double staining of donor-derived cells by immunohistochemistry (A, C). (A) Double 
staining of donor-derived cells with anti-HLA-A2 antibodies (brown) and anti-CCR2 
antibodies (blue). Arrows indicate CCR2(-) HLA-A2(+) cells and arrowheads indicate 
double-positive cells. (B) Frequency of CCR2(+) migrated cells and CCR2(-) migrated 
cells. The number of migrated HLA-A2(+) cells was counted in three independent 
sections and the frequency of CCR2(+) cells and CCR(-) cells were indicated by a bar 
graph. Bars indicate means±S.D. (C) Double staining of donor-derived cells with 
anti-HLA-A2 antibodies (brown) and anti-CX3CR1 antibodies (blue). Arrows show 
double-positive cells, indicating donor origin, and an arrowhead indicates a 
CX3CR1(+)HLA-A2(-) cell, indicating host origin.  



